But I'd love to hear kind of how in North Carolina capital is unlocking value early and identifying these spin out potential spin outs from these R1 universities that are all here.

Yeah, so obviously once you have all the pieces, capital is the next core ingredient.

Now I would say capital in the absence of those other ingredients doesn't do you any good, right? And so you have to have those things first.

But yes, North Carolina I think is a great place for companies to raise translational research capital.

So obviously capital is a really important ingredient once you have all those other pieces in place.

You can't just throw capital after a problem and expect it to solve a problem or grow.

You have to have the right ingredients first.

Define foreign risk for us.